title: Effects of beauvericin, enniatin b and moniliformin on human dendritic cells and macrophages: an in vitro study.
abstract: The aim of this study was to assess the in vitro effects of emerging mycotoxins beauvericin, enniatin B and moniliformin on human dendritic cells and macrophages. Beauvericin and enniatin B were cytotoxic on these cells. IC50 were equal to 1.0 μM, 2.9 μM and 2.5 μM beauvericin for immature dendritic cells, mature dendritic cells and macrophages, respectively. IC50 were equal to 1.6 μM, 2.6 μM and 2.5 μM for immature dendritic cells, mature dendritic cells and macrophages exposed to enniatin B, respectively. Effects on the differentiation process of monocytes into macrophages or into immature dendritic cells as well as effects on dendritic cells maturation have been studied. The differentiation process of monocytes into immature dendritic cells was not disturbed in the presence of beauvericin. Dendritic cells exposed to beauvericin during the maturation process presented a decrease of CCR7 expression and an increase of IL-10 secretion. Monocytes exposed to beauvericin during the differentiation process into macrophages presented a decrease of endocytosis ability. The differentiation process of monocytes into immature dendritic cells was not disturbed in the presence of enniatin B. Dendritic cells exposed to enniatin B during the maturation process presented a decrease of expression of the maturation makers CD80, CD86 and CCR7 and an increase of IL-10 secretion. Monocytes exposed to enniatin B during the differentiation process into macrophages presented a decrease of endocytosis ability and an increase of CD71. CD1a expression and endocytosis capacity were decreased on immature dendritic cells exposed to moniliformin. Monocytes-derived macrophages exposed to moniliformin during the differentiation process presented a decrease of endocytosis ability, and a decrease of CD71 and HLA-DR expression. According to these results, immunological disorders could be observed on human after ingestion of these alimentary toxins.
authors.affiliation: Laboratoire d'Evaluation du Risque Chimique pour le Consommateur-LERCCo, Université Européenne de Bretagne-Université de Bretagne Occidentale-UEB-UBO, UFR Sciences et Techniques, 6 Av. Victor Le Gorgeu, CS93837, 29238 Brest Cedex 3, France.
authors.forename: A S
authors.initials: AS
authors.lastname: Ficheux
authors.forename: Y
authors.initials: Y
authors.lastname: Sibiril
authors.forename: D
authors.initials: D
authors.lastname: Parent-Massin
mesh_terms: D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism; D018949:Antigens, CD1 / Q000235:genetics / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D002470:Cell Survival; D002478:Cells, Cultured; D003503:Cyclobutanes / Q000633:toxicity*; D003713:Dendritic Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D047630:Depsipeptides / Q000633:toxicity*; D004705:Endocytosis / Q000187:drug effects; D006684:HLA-DR Antigens / Q000235:genetics / Q000378:metabolism; D006801:Humans; D020128:Inhibitory Concentration 50; D016753:Interleukin-10 / Q000378:metabolism; D008264:Macrophages / Q000166:cytology / Q000187:drug effects*; D009000:Monocytes / Q000187:drug effects; D010641:Phenotype; D054400:Receptors, CCR7 / Q000235:genetics / Q000378:metabolism; D011990:Receptors, Transferrin / Q000235:genetics / Q000378:metabolism
chemical_list: D015703:Antigens, CD; D018949:Antigens, CD1; C515370:CCR7 protein, human; C419393:CD1a antigen; C068126:CD71 antigen; D003503:Cyclobutanes; D047630:Depsipeptides; D006684:HLA-DR Antigens; D054400:Receptors, CCR7; D011990:Receptors, Transferrin; C100264:enniatins; D016753:Interleukin-10; C004456:beauvericin; C008539:moniliformin
keywords: Beauvericin; Dendritic cell; Enniatin B; Immunotoxicity; Macrophage; Moniliformin